We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

6 hedge funds and large institutions have $29.6K invested in BioCardia, Inc. Warrant in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 4 → 6 (+2)

55% less capital invested

Capital invested by funds: $65.7K → $29.6K (-$36.1K)

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$11K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$7.43K
3
Citadel Advisors
Citadel Advisors
Florida
+$5.55K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$8.73K +$5.55K +10,658 +30%
Osaic Holdings
2
Osaic Holdings
Arizona
$7.65K – – –
UBS Group
3
UBS Group
Switzerland
$5.3K +$11K +21,207 New
G
4
GenTrust
Florida
$3.82K – – –
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$2.67K +$7.43K +14,287 New
Bank of America
6
Bank of America
North Carolina
$1.43K – – –

BCDAW Hedge Fund Activity: Q3 2023 in Review

6 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q3 2023, worth a combined $29.6K — down 55% from $65.7K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new BCDAW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, opening a new position worth an estimated $11K.

  • 6 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q3 2023, up from 4 in Q2 2023.
  • Funds reported $29.6K of BioCardia, Inc. Warrant stock for Q3 2023, down 55% quarter-over-quarter.
  • 2 funds opened new BioCardia, Inc. Warrant positions in Q3 2023 and 0 closed out, a net change of +2 holders.
  • The largest BioCardia, Inc. Warrant buyer in Q3 2023 was UBS Group, an estimated $11K added.

Based on aggregated 13F filings for Q3 2023.